Skip to main content

SeqLL, Inc. (SQL)

NASDAQ: SQL · IEX Real-Time Price · USD
-0.05 (-1.25%)
After-hours:Sep 24, 2021 7:51 PM EDT
-0.01 (-0.25%)
At close: Sep 24, 4:00 PM
Market Cap46.91M
Revenue (ttm)329,495
Net Income (ttm)n/a
Shares Out11.70M
EPS (ttm)n/a
PE Ration/a
Forward PEn/a
Ex-Dividend Daten/a
Previous Close4.02
Day's Range3.92 - 4.25
52-Week Range3.30 - 5.80
Price Targetn/a
Est. Earnings Daten/a

About SQL

SeqLL is an established life sciences instrumentation and research services company engaged in the development of scientific assets and novel intellectual property across multiple “omics” fields (e.g. genomics, proteomics, transcriptomics...). Our mission is to empower researchers with improved genetic tools that enable scientists and physicians to better understand the molecular mechanisms of disease and the underlying biological systems. We believe our proprietary sequencing technology platform has critical advantages over existing Next G...

IndustryDiagnostics & Research
IPO DateAug 27, 2021
CEODaniel Jones
Stock ExchangeNASDAQ
Ticker SymbolSQL
Full Company Profile

Financial Performance

In 2020, SeqLL's revenue was $329,495, a decrease of -38.20% compared to the previous year's $533,129. Losses were -$1.05 million, -57.74% less than in 2019.

Financial Statements


SeqLL Announces Publication of a New Single-Cell Epitranscriptomic Method Powered by SeqLL's tSMS® Platform

Method developed by leading researchers at the Bernstein Laboratory and SeqLL Inc.

2 days ago - GlobeNewsWire

7 Biotech Stocks to Buy That Have Millionaire-Maker Potential

This sector is always a risky area to gamble in. If you have the stomach for it, however, these biotech stocks could see massive gains.

2 weeks ago - InvestorPlace

SeqLL Inc. Announces Pricing of Upsized $13 Million Initial Public Offering

SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ:SQL; SQLLW), a development-stage life sciences...

4 weeks ago - GlobeNewswire

SeqLL IPO Registration Document (S-1)

SeqLL, Inc. has filed to go public with an IPO on the NASDAQ.

5 months ago - SEC